Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of EA3355 in Japanese and Caucasian healthy adult subjects
jRCT2080225068Phase 1Completed
- Sponsor
- EA Pharma Co., Ltd.
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in hepatic disease comparing EA3355 with Placebo (2 arms). Started Feb 2020; status: completed.
02
Drugs
EA3355
03
Conditions
hepatic disease
Beyond the preview
Go deeper on jRCT2080225068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225068.